Hypervolemia leads to disease progression and mortality in patients with heart failure. Intravenous diuretic therapy is the current standard of care for hypervolemic heart failure, but loop diuretics ...
FDA Approves Astellas Pharma's Vaprisol for the Treatment of Hypervolemic Hyponatremia DEERFIELD, Ill., March 2 -- Astellas Pharma US, Inc. today announced that the U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback